Artiva Biotherapeutics, Depreciation And Amortization Over Time

ARTV Stock   10.48  0.63  5.67%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Artiva Biotherapeutics, Performance and Artiva Biotherapeutics, Correlation.
  
Depreciation And Amortization is likely to climb to about 2.4 M in 2024.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artiva Biotherapeutics,. If investors know Artiva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artiva Biotherapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.48)
Revenue Per Share
0.485
Quarterly Revenue Growth
(0.75)
Return On Equity
(0.44)
The market value of Artiva Biotherapeutics, is measured differently than its book value, which is the value of Artiva that is recorded on the company's balance sheet. Investors also form their own opinion of Artiva Biotherapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Artiva Biotherapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artiva Biotherapeutics,'s market value can be influenced by many factors that don't directly affect Artiva Biotherapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artiva Biotherapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Artiva Biotherapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artiva Biotherapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Depreciation And Amortization Analysis

Compare Artiva Biotherapeutics, and related stocks such as Fate Therapeutics, Sana Biotechnology, and Caribou Biosciences Depreciation And Amortization Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
FATE672 K672 K590 K571 K496 K687 K881 K971 K1.2 M4.3 M3.1 M5.8 M13.8 M18.3 M19.2 M
SANA1000100010001000100010001000100010003.9 M5.9 M11.1 M15.6 M30.9 M32.4 M
CRBU1.8 M1.8 M1.8 M1.8 M1.8 M1.8 M1.8 M1.8 M1.8 M1.8 M900 K984 K3.6 M3.5 M2.4 M
RCUS1.3 M1.3 M1.3 M1.3 M1.3 M1.3 M1.3 M2.6 M3.7 M3.6 M4.4 M7.1 M14 MM6.1 M
KPTI83 K83 K122 K144 K323 K634 K717 K713 KM5.4 M972 K789 K621 K530 K503.5 K
XFOR389 K389 K389 K389 K389 K389 K285 K195 K155 K7.8 M351 K1.9 MM419 K398.1 K
HOOK398 K398 K398 K398 K398 K398 K398 K398 K640 K1.4 M4.2 M4.6 M3.6 M3.6 M2.9 M

Artiva Biotherapeutics, and related stocks such as Fate Therapeutics, Sana Biotechnology, and Caribou Biosciences Depreciation And Amortization description

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

My Equities

My Current Equities and Potential Positions

Artiva Biotherapeutics, Common
ARTV
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationCalifornia; U.S.A
ExchangeNASDAQ Exchange
null 10.48

Additional Tools for Artiva Stock Analysis

When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.